# Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

> **NCT03502395** · PHASE1 · COMPLETED · sponsor: **Assiut University** · enrollment: 80 (actual)

## Conditions studied

- Cancer, Breast

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03502395
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2018-01-21
- **Final completion:** 2018-02-13
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03502395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03502395, "Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03502395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*